Moomoo AI 已提取核心信息
The United States Securities and Exchange Commission (SEC) has declared the Form S-1 filed by Transcode Therapeutics, Inc. effective as of January 18, 2024, at 1:00 P.M. The Form S-1 is a registration statement that companies use to register their securities before they can be offered to the public. The effectiveness of this form indicates that Transcode Therapeutics has met all the necessary regulatory requirements to proceed with its public offering.
The United States Securities and Exchange Commission (SEC) has declared the Form S-1 filed by Transcode Therapeutics, Inc. effective as of January 18, 2024, at 1:00 P.M. The Form S-1 is a registration statement that companies use to register their securities before they can be offered to the public. The effectiveness of this form indicates that Transcode Therapeutics has met all the necessary regulatory requirements to proceed with its public offering.
美国证券交易委员会（SEC）宣布，Transcode Therapeutics, Inc.提交的S-1表格自2024年1月18日下午1点起生效。S-1表格是公司在向公众发行证券之前用来注册证券的注册声明。该表格的有效性表明，Transcode Therapeutics已经满足了进行公开募股的所有必要监管要求。
美国证券交易委员会（SEC）宣布，Transcode Therapeutics, Inc.提交的S-1表格自2024年1月18日下午1点起生效。S-1表格是公司在向公众发行证券之前用来注册证券的注册声明。该表格的有效性表明，Transcode Therapeutics已经满足了进行公开募股的所有必要监管要求。
有用
没用